IRIS Institutional Research Information System - OPENBS Open Archive UniBS

MISSALE, Mariacristina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.609
EU - Europa 5.674
AS - Asia 2.754
SA - Sud America 22
AF - Africa 20
OC - Oceania 20
Continente sconosciuto - Info sul continente non disponibili 15
Totale 20.114
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.553
CN - Cina 1.955
UA - Ucraina 1.762
PL - Polonia 922
IT - Italia 703
DE - Germania 661
FI - Finlandia 433
FR - Francia 411
HK - Hong Kong 379
GB - Regno Unito 328
IE - Irlanda 286
IN - India 249
SE - Svezia 59
CA - Canada 55
BE - Belgio 48
TR - Turchia 44
VN - Vietnam 42
IR - Iran 36
AU - Australia 18
SG - Singapore 18
EU - Europa 15
CH - Svizzera 14
MU - Mauritius 14
BR - Brasile 10
KR - Corea 8
CL - Cile 7
NL - Olanda 7
ES - Italia 6
RU - Federazione Russa 6
JP - Giappone 5
RO - Romania 5
BG - Bulgaria 4
IL - Israele 3
LU - Lussemburgo 3
AR - Argentina 2
BA - Bosnia-Erzegovina 2
BO - Bolivia 2
EE - Estonia 2
ET - Etiopia 2
GR - Grecia 2
HU - Ungheria 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PK - Pakistan 2
PT - Portogallo 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
BD - Bangladesh 1
EG - Egitto 1
GE - Georgia 1
HR - Croazia 1
JO - Giordania 1
KE - Kenya 1
MK - Macedonia 1
MY - Malesia 1
PA - Panama 1
PE - Perù 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SL - Sierra Leone 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 20.114
Salva come PNG Salva come JPEG
Città #
Fairfield 1.569
Woodbridge 1.486
Jacksonville 1.286
Warsaw 922
Houston 905
Ann Arbor 790
Ashburn 763
Cambridge 681
Chandler 579
Seattle 576
Wilmington 569
Princeton 527
Nanjing 466
Hong Kong 376
Brescia 289
Dublin 284
Dearborn 279
Beijing 277
New York 220
Helsinki 195
Nanchang 181
Shenyang 146
Hebei 131
Des Moines 118
Jinan 96
Tianjin 96
Changsha 82
San Diego 77
Milan 73
Pune 71
Jiaxing 66
Lancaster 64
Shanghai 61
San Mateo 48
Kunming 47
Toronto 47
Brussels 42
Dong Ket 42
Hangzhou 42
Verona 42
Ningbo 39
Kocaeli 36
Augusta 33
Ardabil 32
Leawood 32
London 32
San Francisco 32
San Donà Di Piave 31
Haikou 28
Zhengzhou 28
Monmouth Junction 27
Taizhou 27
Lanzhou 20
Guangzhou 19
Norwalk 17
Boardman 16
Orange 15
Rome 15
Basel 14
Changchun 14
Fuzhou 14
Taiyuan 14
Hefei 13
Kilburn 12
Auburn Hills 11
Canberra 9
Acton 8
Los Angeles 8
Mumbai 7
New Bedfont 7
Redwood City 7
São Paulo 7
Teramo 7
Brooklyn 6
Lappeenranta 6
Melbourne 6
Hounslow 5
Phoenix 5
Bologna 4
Hanover 4
Madrid 4
Ottawa 4
Oxford 4
Paris 4
Sofia 4
Torino 4
Xian 4
Bolzano 3
Cattolica 3
Chiswick 3
Dallas 3
Fremont 3
Fulda 3
Indiana 3
Luxembourg 3
Macerata 3
Mons 3
Padova 3
Santa Clara 3
Tokyo 3
Totale 15.345
Salva come PNG Salva come JPEG
Nome #
Redistribution of DAT/α-synuclein complexes visualized by “in situ” proximity ligation assay in transgenic mice modelling early Parkinson’s disease 249
Dopamine transporter/α-synuclein complexes are altered in the post mortem caudate putamen of Parkinson’s disease: An in situ proximity ligation assay study 244
GPNMB/OA protein increases the invasiveness of human metastatic prostate cancer cell lines DU145 and PC3 through MMP-2 and MMP-9 activity 230
The Contribution of -Synuclein Spreading to Parkinson’s Disease Synaptopathy 217
Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine d3 receptors and akt-mtorc1 signaling 211
Pre-synaptic dopamine D(3) receptor mediates cocaine-induced structural plasticity in mesencephalic dopaminergic neurons via ERK and Akt pathways 204
Bright light exposure reduces TH-positive dopamine neurons: implications of light pollution in Parkinson's disease epidemiology. 183
Antisecretive and Antitumor Activity of Abiraterone Acetate in Human Adrenocortical Cancer: A Preclinical Study. 179
The "in situ" proximity ligation assay to probe protein-protein interactions in intact tissues 156
Role of Dopamine D2/D3 Receptors in Development, Plasticity, and Neuroprotection in Human iPSC-Derived Midbrain Dopaminergic Neurons 152
Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains 150
IN VITRO ANTITUMOR ACTIVITY OF PROGESTERONE IN HUMAN ADRENOCORTICAL CARCINOMA 140
Alpha-synuclein modulates NR2B-containing NMDA receptors and decreases their levels after rotenone exposure 134
The D3 dopamine receptor: From structural interactions to function. 132
Palbociclib inhibits proliferation of human adrenocortical tumor cells 129
A mechanism additional to cyclic AMP accumulation for vasoactive intestinal peptide-induced prolactin release. 125
Shp-2 knockdown prevents l-dopa-induced dyskinesia in a rat model of Parkinson's disease 123
Cellular mechanisms for neurotensin receptor-mediated release of prolactin. 121
Persistent activation of the D1R/Shp-2/Erk1/2 pathway in L-DOPA-induced dyskinesia in the 6-hydroxy-dopamine rat model of Parkinson's disease 120
Age-related changes of enkephalin in rat spinal cord 119
Dopamine D3 and acetylcholine nicotinic receptor heteromerization in midbrain dopamine neurons: Relevance for neuroplasticity 114
A new pharmacological approach to the facilitation of acetylcholine transmission. 113
Alpha-synuclein aggregation and cell death triggered by energy deprivation and dopamine overload are counteracted by D2/D3 receptor activation 113
The novel hybrid agonist HyNDA-1 targets the D3R-nAChR heteromeric complex in dopaminergic neurons 113
The 5-alpha reductase inhibitor finasteride reduces dyskinesia in a rat model of Parkinson's disease 112
The proximity ligation assay: an high throughput technique for protein analysis in neuroscience 111
Bifunctional compounds targeting both D2 and non-α7 nACh receptors: design, synthesis and pharmacological characterization. 110
Differential effects of caffeine on dihydroxyphenylacetic acid concentrations in various rat brain dopaminergic structures 109
Pharmacological basis for dopamine D-2 receptor diversity 109
D2 dopamine receptors associated with inhibition of dopamine release from rat neostriatum are independent of cyclic AMP. 109
Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate 109
Acute hemodynamic effects of the two dopaminergic agonists ibopamine and dihydroergotamine, a comparison with the parent compound. 108
From α-synuclein to synaptic dysfunctions: new insights into the pathophysiology of Parkinson's disease 107
Receptor Heteromers in Parkinson's Disease and L-DOPA-Induced Dyskinesia 107
Nerve growth factor suppresses the transforming phenotype of human prolactinomas 106
Dopamine receptors are present in rat and human esophagus 105
The tyrosine phosphatase Shp-2 interacts with the dopamine D(1) receptor and triggers D(1) -mediated Erk signaling in striatal neurons. 105
Identification of neurotensin receptors associated with calcium channels and prolactin release in rat pituitary. 105
Synapsin III alterations in Parkinson's disease 105
Acute scopolamine treatment decreases dopamine metabolism in rat hippocampus and frontal cortex 104
The neurobiology of dopamine receptors: evolution from the dual concept to heterodimer complexes 103
Evidence for the presence of D1 and D2 dopamine receptors in the rat adrenal cortex 103
Dopaminergic inhibition of prolactin release and calcium influx induced by neurotensin in anterior pituitary is independent of cyclic AMP system. 103
Mitochondrial Dysfunction and Alpha-Synuclein Synaptic Pathology in Parkinson’s Disease: Who’s on First? 103
Sex-related variations in serum nerve growth factor concentration in humans. 102
Chronic lead exposure alters dopaminergic mechanisms in rat pituitary 102
Vasoactive Intestinal Polypeptide (VIP) selectively stimulates prolactin release in healthy women 102
Depletion of Progranulin Reduces GluN2B-Containing NMDA Receptor Density, Tau Phosphorylation, and Dendritic Arborization in Mouse Primary Cortical Neurons 102
Nicotine prevents alpha-synuclein accumulation in mouse and human iPSC-derived dopaminergic neurons through activation of the dopamine D3- acetylcholine nicotinic receptor heteromer 102
Ormoni Anteroipofisari 101
Chronic lead exposure differentially affects dopamine transport in rat striatum and nucleus accumbens. 101
The differential coupling mechanism of dopamine D-2 receptor subtypes: importance for the actions of neuroleptic drugs 101
Nerve growth factor, D2 receptor isoforms, and pituitary tumors 101
Effect of suloctidil on dopaminergic transmission in various rat brain areas: possible uses as a drug for the elderly 100
Identification of D2 dopaminergic receptors in bovine adrenal cortex. 100
Post-synaptic D1 and D2 dopamine receptors are present in rabbit renal and mesenteric arteries 100
Effect of lead exposure on dopaminergic receptors in rat striatum and nucleus accumbens 100
Repeated administration of (−) sulpiride and SCH 23390 differentially up-regulate D-1 and D-2 dopamine receptor function in rat mesostriatal areas but not in cortical-limbic brain regions 100
α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons 100
Opposing roles for D-1 and D-2 dopamine receptors in the regulation of lower esophageal sphincter motility in the rat. 99
Nerve growth factor in the anterior pituitary: localization in mammotroph cells and co-secretion with prolactin by a dopamine-regulated mechanism 99
Nerve growth factor directs differentiation of the bipotential cell line GH-3 into the mammotroph phenotype 98
Modification of the function of D1 and D2 dopamine receptors in striatum and nucleus accumbens of rats chronically treated with haloperidol. 98
Different neurotransmitter systems are involved in the development of esophageal achalasia 97
Evidence for the presence of both D-1 and D-2 dopamine receptors in human esophagus. 97
The NMDA/D1 receptor complex as a new target in drug development 97
A superfusion method for the study of calcium fluxes from pituitary cells. 97
Properties of benzodiazepine binding sites in peripheral blood lymphocytes 97
Epidermal growth factor induces the functional expression of dopamine receptors in the GH3 cell line 96
Dimerization of dopamine D1 and D3 receptors in the regulation of striatal function 96
Neuropeptidergic inhibitory regulation of met-enkephalin immunoreactive material release from rat spinal cord in vitro. 96
Role of receptor heterodimers in the development of L-dopa-induced dyskinesias in the 6-hydroxydopamine rat model of Parkinson's disease. 95
Angiotensin II differentially affects cyclic AMP formation in intact adrenal glomerulosa cells and in purified membrane preparations 94
Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas. II. Dorsal hippocampus 93
Nerve growth factor in pituitary development and pituitary tumors 93
Dopamine D2 receptors modulate aldosterone secretion 93
[Functional relation of dopamine receptor stimulation and ionic fluxes in lactotroph cells]. 93
Nerve growth factor signaling in prostate health and disease. 93
Anterior pituitary hypoplasia and dwarfism in mice lacking the dopamine transporter 92
Repeated reserpine administration up-regulates the transduction mechanisms of D1 receptors without changing the density of [3H]SCH23390 binding 92
Inhibition of aldosterone secretion by dopamine, ibopamine, and dihydroergotoxine in patients with congestive heart failure 92
Ruolo dei recettori della dopamina nella regolazione motoria dello sfintere esofageo inferiore del ratto 92
Caveolins in rhabdomyosarcoma 92
Derivation of midbrain dopaminergic neurons from human inducible pluripotent stem cells to model neurological disorders. 91
Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines 91
Nuclear Factor-κB Dysregulation and α-Synuclein Pathology: Critical Interplay in the Pathogenesis of Parkinson’s Disease 91
Nerve growth factor and bromocriptine: a sequential therapy for human bromocriptine-resistant prolactinomas 90
Dopamine D3 receptor-preferring agonists increase dendrite arborization of mesencephalic dopaminergic neurons via extracellular signal-regulated kinase phosphorylation. 90
Peripheral and central mechanisms of action of serotoninergic anorectic drugs. 90
Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas. I. Frontal cortex 89
Nerve growth factor promotes the differentiation of pituitary mammotroph cells in vitro 89
Identification and characterization of postsynaptic D1 and D2 dopamine receptors in the cardiovascular system 88
Nerve growth factor suppresses the tumoral phenotype of human prolactinomas 88
Inhibition of aldosterone response to sodium depletion in man by stimulation of dopamine DA2 receptors. 88
Differential up-regulation of D-1 and D-2 dopamine receptor function in mesostriatal areas but not in cortical-limbic brain regions of rats chronically treated with (?)sulpiride and SCH 23390 88
NMDA receptor subunits are phosphorylated by activation of neurotrophin receptors in PSD of rat spinal cord 87
Reciprocal regulation of dopamine D1 and D3 receptor function and trafficking by heterodimerization 87
CaMKII-dependent phosphorylation regulates SAP97/NR2A interaction 86
Involvement of Synapsin III in the onset of alpha-synuclein synaptic pathology in Parkinson’s disease 86
Nerve growth factor and retinoic acid inhibit proliferation and invasion in thyroid tumor cells. 85
Totale 11.203
Salva come PNG Salva come JPEG
Categoria #
all - tutte 88.774
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 88.774
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019932 0 0 0 0 0 0 0 0 0 0 493 439
2019/20206.063 936 176 192 654 301 712 603 681 377 853 223 355
2020/20213.673 79 401 84 409 123 411 193 465 565 287 536 120
2021/20222.156 195 455 54 72 16 49 138 121 88 277 177 514
2022/20231.786 306 18 38 139 151 527 5 161 274 39 61 67
2023/20241.445 110 32 142 132 93 372 60 53 387 30 34 0
Totale 20.931